Skip to content

PANDA-Regional Feasibility Study of a Smartphone Pain Management Application

The At-home Feasibility Evaluation of PANDA-Regional, a Smartphone Application Designed to Support Post-operative Pain Management in Patients Undergoing Peripheral Nerve Blocks

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03369392
Enrollment
29
Registered
2017-12-12
Start date
2017-12-11
Completion date
2019-03-31
Last updated
2019-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Conduction, Postoperative Pain

Brief summary

Despite the numerous benefits of peripheral nerve blocks (PNBs) over general anesthesia (GA) in a variety of surgical procedures, PNBs can be associated with increased post-operative pain if pain medications are not taken correctly (titrated). Unfortunately, this is a common occurrence as patients often have difficulty titrating medications in the absence of direct medical care. PANDA, a smartphone-based postoperative pain management tool, is designed to address this issue by helping patients manage their pain medications. The purpose of this study is to demonstrate the feasibility of this application in patients who are discharged after receiving PNBs. The goal is to identify areas of improvement for the application itself. It is hypothesize that PANDA will be successful in supporting patients' postoperative pain management.

Detailed description

As above

Interventions

OTHERPanda application

A smartphone-based postoperative pain management tool

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Undergoing ambulatory surgical procedures that require peripheral nerve blocks for which there is an anticipated post-surgical pain model * Planned post-discharge analgesic medications including non-steroidal anti-inflammatory drugs, acetaminophen and/or opioids for at least 2 days * ASA I-III * Written informed consent * Have a smartphone device at their disposal

Exclusion criteria

* Inability or refusal to provide informed consent * Presence of significant cognitive impairment, visual impairments, neurological injury, or psychomotor dysfunction that impairs ability to use the app * Inability to follow study instructions and complete questionnaires in English

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the PANDA application2-7 days post-operativelyMeasured by assessing the participants' compliance with the application in supporting ongoing pain assessments and analgesic administration.

Secondary

MeasureTime frameDescription
Identify usability issues2-7 days post-operativelyAssessed by having participants complete a Computer Systems Usability Questionnaire (CSUQ) and a brief phone interview

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026